AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 8 filers reported holding AYALA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $372,000 | -79.2% | 341,030 | -24.2% | 0.01% | -75.0% |
| Q1 2022 | $1,790,000 | -68.5% | 449,731 | -32.7% | 0.06% | -56.6% |
| Q4 2021 | $5,683,000 | -25.0% | 667,816 | 0.0% | 0.13% | -2.3% |
| Q3 2021 | $7,573,000 | +11.3% | 667,816 | 0.0% | 0.13% | +30.7% |
| Q2 2021 | $6,805,000 | -6.6% | 667,816 | 0.0% | 0.10% | -1.9% |
| Q1 2021 | $7,286,000 | -4.2% | 667,816 | 0.0% | 0.10% | +12.0% |
| Q4 2020 | $7,606,000 | -3.1% | 667,816 | +0.2% | 0.09% | -36.1% |
| Q3 2020 | $7,853,000 | +17.4% | 666,666 | 0.0% | 0.14% | +17.1% |
| Q2 2020 | $6,687,000 | – | 666,666 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 542,977 | $5,533,000 | 1.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,364 | $238,000 | 0.11% |
| Redmile Group, LLC | 667,816 | $6,805,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,962 | $326,000 | 0.01% |
| Marshall Wace North America L.P. | 49,266 | $502,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 704,363 | $7,178,000 | 0.00% |
| Chevy Chase Trust Holdings, LLC | 15,000 | $153,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 470 | $4,000 | 0.00% |
| UBS Group AG | 5,509 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |